Your browser doesn't support javascript.
loading
Tumor and Microenvironment Evolution during Immunotherapy with Nivolumab.
Riaz, Nadeem; Havel, Jonathan J; Makarov, Vladimir; Desrichard, Alexis; Urba, Walter J; Sims, Jennifer S; Hodi, F Stephen; Martín-Algarra, Salvador; Mandal, Rajarsi; Sharfman, William H; Bhatia, Shailender; Hwu, Wen-Jen; Gajewski, Thomas F; Slingluff, Craig L; Chowell, Diego; Kendall, Sviatoslav M; Chang, Han; Shah, Rachna; Kuo, Fengshen; Morris, Luc G T; Sidhom, John-William; Schneck, Jonathan P; Horak, Christine E; Weinhold, Nils; Chan, Timothy A.
Afiliação
  • Riaz N; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Immunogenomics and Precision Oncology Platform, Memorial Sloan Kettering Cancer Center, New Yor
  • Havel JJ; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
  • Makarov V; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Immunogenomics and Precision Oncology Platform, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
  • Desrichard A; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
  • Urba WJ; Earle A. Chiles Research Institute, Providence Cancer Center, Portland, OR 97213, USA.
  • Sims JS; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Immunogenomics and Precision Oncology Platform, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
  • Hodi FS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
  • Martín-Algarra S; Medical Oncology, Clínica Universidad de Navarra, Instituto de Investigación Sanitaria de Navarra, 31008 Pamplona, Spain.
  • Mandal R; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
  • Sharfman WH; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.
  • Bhatia S; Fred Hutchinson Cancer Research Center, University of Washington, Seattle, WA 98105, USA.
  • Hwu WJ; Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Gajewski TF; Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL 60637, USA.
  • Slingluff CL; Department of Surgery and University of Virginia Cancer Center, University of Virginia School of Medicine, Charlottesville, VA 22908, USA.
  • Chowell D; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Immunogenomics and Precision Oncology Platform, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
  • Kendall SM; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Immunogenomics and Precision Oncology Platform, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
  • Chang H; Bristol-Myers Squibb, Princeton, NJ 08648, USA.
  • Shah R; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
  • Kuo F; Immunogenomics and Precision Oncology Platform, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
  • Morris LGT; Immunogenomics and Precision Oncology Platform, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
  • Sidhom JW; Department of Biomedical Engineering, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
  • Schneck JP; Department of Biomedical Engineering, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
  • Horak CE; Bristol-Myers Squibb, Princeton, NJ 08648, USA.
  • Weinhold N; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. Electronic address: weinholn@mskcc.org.
  • Chan TA; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Immunogenomics and Precision Oncology Platform, Memorial Sloan Kettering Cancer Center, New Yor
Cell ; 171(4): 934-949.e16, 2017 Nov 02.
Article em En | MEDLINE | ID: mdl-29033130
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Microambiente Tumoral / Imunoterapia / Melanoma / Anticorpos Monoclonais / Antineoplásicos Limite: Humans Idioma: En Revista: Cell Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Microambiente Tumoral / Imunoterapia / Melanoma / Anticorpos Monoclonais / Antineoplásicos Limite: Humans Idioma: En Revista: Cell Ano de publicação: 2017 Tipo de documento: Article